ClinicalTrials.gg
Drug

Prucalopride clinical trials

Also written Resolor.

studies test it
57
open now
5
in phase 3
20
first study started
1994

How each study uses prucalopride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the prucalopride studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Dec 2018 · MOTEGRITY · NDA 210166 (FDA, Drugs@FDA)
European Union
14 Oct 2009 · Resolor · EMEA/H/C/001012 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Prucalopride
51
Prucalopride 2mg
4
RESTORAN
2

Brand

Resolor
27

Development codes

TAK-555
1

Studies by the year they started

55 studies that test it; most in 1998 (9); 1 more planned to start later

Studies that test prucalopride, by start year
YearStudies
19941
19952
19961
19972
19989
19992
20001
20092
20104
20113
20121
20134
20143
20161
20174
20181
20191
20214
20224
20231
20253
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
10
Phase 2
13
Phase 3
20
Phase 4
10
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 30 · Other 27

Movetis (22) · Shire (5) · University of Oxford (4) · Universitaire Ziekenhuizen KU Leuven (3) · University of Calgary (2) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (2) · KU Leuven (1) · Ain Shams University (1)

Often tested with

Tested in the same studies.

Polyethylene Glycols (3) · Bisacodyl (2) · Metoclopramide (1) · Ascorbic Acid (1) · Diatrizoate Meglumine (1) · Diatrizoate (1) · Picosulfate sodium (1) · Buspirone (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test prucalopride.

Studies

Open first, then newest update. How each study uses prucalopride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 57

See all 57 studies that test prucalopride →

Given beside what is tested · 1 — prucalopride is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with prucalopride

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call prucalopride · ClinicalTrials.gg INT004227

  • MeSH (NLM) C406662prucaloprideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 0A09IUW5TPPRUCALOPRIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 2107310Confirmed FDA, Wikidata
  • Wikidata Q68484prucaloprideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C74386PrucaloprideOne source FDA
  • DrugBank DB06480One source Wikidata

Also registered as prucalopride succinate (UNII 4V2G75E1CK · RxNorm 2107309).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.